严重肾功能不全与静脉血栓栓塞抗凝期间出血风险
两公式在40.7%的患者中结果不一致,但无论用哪种公式识别,严重肾功能不全患者抗凝3个月内主要出血风险均升高。
要点
- CG与CKD-EPI公式对严重肾功能不全的识别在40.7%患者中不一致。
- 严重肾功能不全患者抗凝3个月内主要出血风险增加约1.7-2.5倍。
- 临床应关注肾功能评估公式选择对出血风险分层的影响。
核心结论
- CG与CKD-EPI公式识别出不同的严重肾功能不全VTE患者亚组,40.7%结果不一致。
- 无论采用哪种公式,严重肾功能不全患者抗凝治疗期间主要出血风险均显著升高。
研究设计与样本
- 比较CG和/或CKD-EPI公式定义的严重肾功能不全(eGFR<30 mL/min或<30 mL/min/1.73 m2)患者抗凝前3个月的临床特征与结局。
- 主要结局为主要出血。
主要发现
- 至少一种公式定义严重肾功能不全的患者共4676例,其中1904例(40.7%)未被另一公式确认。
- 任一公式严重肾功能不全 vs 无:主要出血OR=2.26(95%CI 2.01-2.53)。
- 仅CG<30 vs 无:OR=1.72(95%CI 1.37-2.13)。
- 仅CKD-EPI<30 vs 无:OR=2.34(95%CI 1.77-3.05)。
- CG+CKD-EPI均<30 vs 均>30:OR=2.47(95%CI 2.16-2.83)。
临床怎么用
- VTE患者抗凝前应评估肾功能,严重肾功能不全者需警惕主要出血风险。
- CG与CKD-EPI公式识别结果可能不一致,临床解读肾功能分层时需注意公式差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Detection of severe renal impairment in patients with venous thromboembolism (VTE) is mandatory both for selecting anticoagulant therapy and for evaluating major bleeding risk, increased by severe renal impairment. OBJECTIVES: To determine whether the Cockcroft and Gault (CG) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formulas identify severe renal impairment in the same VTE patients presenting the same risk of major bleeding. PATIENTS/METHODS: We compared clinical characteristics and outcomes during the first 3 months of anticoagulation between VTE patients in the RIETE registry with severe renal impairment according to the CG and/or CKD-EPI formula (estimated glomerular filtration rate <30 mL/min and <30 mL/min/1.73 m2 , respectively). The primary outcome was major bleeding. RESULTS: Up to October 2017, 41 796 patients were included in RIETE. Among the 4676 patients with severe renal impairment according to at least one of the formulas, this was not confirmed by the other formula in 1904 (40.7%). Major bleeding risk was increased in every patient subgroup with severe renal impairment vs patients without this condition (CG or CKD-EPI < 30: odds ratio [OR] = 2.26, 95% confidence interval [CI 2.01-2.53], only CG < 30: OR = 1.72, 95% CI [1.37-2.13], only CKD-EPI < 30: OR = 2.34, 95% CI [1.77-3.05], CG+CKD-EPI < 30: OR = 2.47, 95% CI [2.16-2.83], all vs CG+CKD-EPI > 30). CONCLUSION: The CG and CKD-EPI formulas identify different subgroups of patients with severe renal impairment, leading to discordant results in 40.7% of these patients. Irrespective of the formula used for their identification, patients with severe renal impairment have a higher risk of major bleeding under anticoagulant therapy.
引用
- Catella J, Bertoletti L, Mismetti P, et al. Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolism. J Thromb Haemost. 2020. PMID: 32299150. doi:10.1111/jth.14837
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。